Cite
HARVARD Citation
Suman, S. et al. (2021). Combined 177Lu‐PSMA‐617 PRLT and abiraterone acetate versus 177Lu‐PSMA‐617 PRLT monotherapy in metastatic castration‐resistant prostate cancer: An observational study comparing the response and durability. Prostate. 81 (15), pp. 1225-1234. [Online].